Gudepalya Renukaiah Rudramurthy

Dr. Gudepalya Renukaiah Rudramurthy

Foundation for Neglected Disease Research, Bengaluru, India
orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 June 2016 in Molecules
Verified
Journal Article
Open access
PDF file
GRGudepalya Renukaiah Rudramurthy
Gudepalya Renukaiah Rudramurthy
Mallappa Kumara SwamyMallappa Kumara Swamy
Mallappa Kumara Swamy
USUma Rani Sinniah
Uma Rani Sinniah
Ali GhasemzadehAli Ghasemzadeh
Ali Ghasemzadeh
Antimicrobial substances may be synthetic, semisynthetic, or of natural origin (i.e., from plants and animals). Antimicrobials are considered “miracle drugs” and can determine if an infected patient/animal recovers or dies. However, the misuse of antimicrobials has led to the development of multi-drug-resistant bacteria, which is one of the greatest challenges for healthcare practitioners and is a significant global threat. The major concern with the development of antimicrobial resistance is the spread of resistant organisms. The replacement of conventional antimicrobials by new technology to counteract antimicrobial resistance is ongoing. Nanotechnology-driven innovations provide hope for patients and practitioners in overcoming the problem of drug resistance. Nanomaterials have tremendous potential in both the medical and veterinary fields. Several nanostructures comprising metallic particles have been developed to counteract microbial pathogens. The effectiveness of nanoparticles (NPs) depends on the interaction between the microorganism and the NPs. The development of effective nanomaterials requires in-depth knowledge of the physicochemical properties of NPs and the biological aspects of microorganisms. However, the risks associated with using NPs in healthcare need to be addressed. The present review highlights the antimicrobial effects of various nanomaterials and their potential advantages, drawbacks, or side effects. In addition, this comprehensive information may be useful in the discovery of broad-spectrum antimicrobial drugs for use against multi-drug-resistant microbial pathogens in the near future.

10 August 2018 in JBIC Journal of Biological Inorganic Chemistry
Verified
Journal Article
Closed access
PDF file
GRGudepalya Renukaiah Rudramurthy
Gudepalya Renukaiah Rudramurthy
Mallappa Kumara SwamyMallappa Kumara Swamy
Mallappa Kumara Swamy

1 June 2012 in Veterinary Parasitology
Verified
Journal Article
Closed access
PSP.P. Sengupta
P.P. Sengupta
MBM. Balumahendiran
M. Balumahendiran
Vinayagamurthy BalamuruganVinayagamurthy Balamurugan
Vinayagamurthy Balamurugan
GRGudepalya Renukaiah Rudramurthy
Gudepalya Renukaiah Rudramurthy
KPK. Prabhudas
K. Prabhudas

1 January 2020 in BioMed Research International
Verified
Journal Article
Open access
PDF file
XZXudong Zhang
Xudong Zhang
YBYuzhuo Bai
Yuzhuo Bai
YWYun Wang
Yun Wang
CWChunlan Wang
Chunlan Wang
JFJianhua Fu
Jianhua Fu
YDYue Deng
Yue Deng
Honeydew melon (Cucumis melo L.) is an oval‐shaped delicious fruit of one cultivar group of the muskmelon with immense nutritional importance and is extensively consumed by many tropical countries. The effect of various organic solvents on the recovery of phytochemicals from honeydew melon plant fruits and seeds was assessed. Further, High‐Performance Liquid Chromatography (HPLC) was used to examine and assess the contents of phenolic acid (gallic acid) and flavonoid (rutin) compounds. The use of gas chromatography–mass spectrometry (GC‐MS) analysis explained the presence of volatile phytocompounds in the extracts. The use of organic solvents had a substantial impact on the total dry weight and extract yield. In general, the solvent‐extracted constituents remained in the order of methanol>chloroform>distilled water for both honeydew melon seeds and whole fruit. 3‐(4,5‐Dimethylthiazol‐2‐yl)‐2,5‐diphenyl tetrazolium bromide (MTT) was used to assess the cytotoxicity effect against PC3, HCT116, HeLa, and Jurkat cell lines. The chloroform extract exhibited a good cytotoxic activity against all cell lines as compared to other solvent extracts. HPLC analysis revealed the occurrence of gallic acid content of 0.102 ± 0.23 mg/10 mg of dry whole fruit extract, while 10 mg of dry seed extract contained only 0.022 ± 0.12 mg of gallic acid content. Likewise, rutin content was observed to be 0.224 ± 0.31 mg and 0.1916 ± 0.82 mg/10 mg of dry whole fruit and seed extract, respectively. Further, GC‐MS analysis revealed the presence of a total of 37 compounds in chloroform extract of whole fruit, while only 14 compounds were found in seed extract. Nevertheless, more examinations are needed to identify and characterize other metabolites from honeydew melon and evaluate their pharmacological importance.

24 January 2023 in Vaccines
Verified
Journal Article
Open access
PDF file
RMRajeev Mehla
Rajeev Mehla
PKPrasad Kokate
Prasad Kokate
SBSarika R. Bhosale
Sarika R. Bhosale
VVVivek Vaidya
Vivek Vaidya
SNShridhar Narayanan
Shridhar Narayanan
LYLeena Ravindra Yeolekar
Leena Ravindra Yeolekar
Children are at risk of infection from severe acute respiratory syndrome coronavirus-2 virus (SARS-CoV-2) resulting in coronavirus disease (COVID-19) and its more severe forms. New-born infants are expected to receive short-term protection from passively transferred maternal antibodies from their mothers who are immunized with first-generation COVID-19 vaccines. Passively transferred antibodies are expected to wane within first 6 months of infant’s life, leaving them vulnerable to COVID-19. Live attenuated vaccines, unlike inactivated or viral-protein-based vaccines, offer broader immune engagement. Given effectiveness of live attenuated vaccines in controlling infectious diseases such as mumps, measles and rubella, we undertook development of a live attenuated COVID-19 vaccine with an aim to vaccinate children beyond 6 months of age. An attenuated vaccine candidate (dCoV), engineered to express sub-optimal codons and deleted polybasic furin cleavage sites in the spike protein of the SARS-CoV-2 WA/1 strain, was developed and tested in hamsters. Hamsters immunized with dCoV via intranasal or intramuscular routes induced high levels of neutralizing antibodies and exhibited complete protection against the SARS-CoV-2 wild-type isolates, i.e., the Wuhan-like (USA-WA1/2020) and Delta variants (B.1.617.2) in a challenge study. In addition, the dCoV formulated with the marketed measles–rubella (MR) vaccine, designated as MR-dCoV, administered to hamsters via intramuscular route, also protected against both SARS-CoV-2 challenges, and dCoV did not interfere with the MR vaccine-mediated immune response. The safety and efficacy of the dCoV and the MR-dCoV against both variants of SARS-CoV-2 opens the possibility of early immunization in children without an additional injection.

1 October 2014 in Veterinary Parasitology
Verified
Journal Article
Closed access
PSP.P. Sengupta
P.P. Sengupta
GRGudepalya Renukaiah Rudramurthy
Gudepalya Renukaiah Rudramurthy
MLM. Ligi
M. Ligi
MRM. Roy
M. Roy
Vinayagamurthy BalamuruganVinayagamurthy Balamurugan
Vinayagamurthy Balamurugan
HRH. Rahman
H. Rahman